Correlation of expression of human arrest-defective-1 (hard1) protein with breast cancer

Cancer Investigation

Volumn 27, Issue 10, 2009, Pages 978-983

  Yu, Min ^a   Ma, Mingxing ^a   Huang, Chao ^a   Yang, Hui ^b   Lai, Jianhua ^a   Yan, Shan ^a   Li, Lin ^b   Xiang, Mingjun ^a   Tan, Deyong ^a  

^a YUNNAN UNIVERSITY   (China)

^b FIRST PEOPLE S HOSPITAL OF YUNNAN PROVINCE   (China)

Author keywords

Breast cancer; Cell proliferation; HARD1; MCF 7

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; HUMAN ARREST DEFECTIVE 1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ACETYLTRANSFERASES; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; CELL PROLIFERATION; DNA, ANTISENSE; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; TIME FACTORS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 70450218735     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900902769723     Document Type: Article

References (24)

1. Polevoda, B.; Norbeck, J.; Takakura, H.; Blomberg, A.; Sherman, F. Identification and specificities of N-terminal acetyltransferases from Saccharomyces cerevisiae. EMBO J 1999, 18, 6155-6168.
2. Arnesen, T.; Anderson, D.; Baldersheim, C.; Lanotte, M.; Varhaug, J.E.; Lillehaug, J.R. Identification and characterization of the human ARD1-NATH protein acetyltransferase complex. Biochem J 2005, 386, 433-443.
3. Bilton, R.; Mazure, N.; Trottier, E.; Hattab, M.; Dery, M.A.; et al. Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1alpha and is not induced by hypoxia or HIF. J Biol Chem 2005, 280, 31132-31140.
4. Ingram, A.K.; Cross, G.A.; Horn, D. Genetic manipulation indicates that ARD1 is an essential N(infinity)-acetyltransferase in Trypanosoma brucei. Mol Biochem Parasitol 2000, 111, 309-317.
5. Whiteway, M.; Szostak, J.W. The ARD1 gene of yeast functions in the switch between the mitotic cell cycle and alternative developmental pathways. Cell 1985, 43, 483-492.
6. Whiteway, M.; Freedman, R.; Van Arsdell, S.; Szostak, J.W.; Thorner, J. The yeast ARD1 gene product is required for repression of cryptic mating-type information at the HML locus. Mol Cell Biol 1987, 7, 3713-3722.
7. Midorikawa, Y.; Tsutsumi, S.; Taniguchi, H.; Ishii, M.; Kobune, Y.; et al. Identification of genes associated with dedifferentiation of hepatocellular carcinoma with expression profiling analysis. Jpn J Cancer Res 2002, 93, 636-643.
8. Lim, J.H.; Park, J.W.; Chun, Y.S. Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation. Cancer Res 2006, 66, 10677-10682.
9. Fisher, B.; Costantino, J.P.; Wickerham, D.L.; Redmond, C.K.; Kavanah, M.; et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998, 90, 1371-1388.
10. Veronesi, U.; Maisonneuve, P.; Costa, A.; Sacchini, V.; Maltoni, C.; et al. Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomised women-Italian Tamoxifen Prevention Study. Lancet 1998, 352, 93-97.
11. Clayton, E.W.; Steinberg, K.K.; Khoury, M.J.; Thomson, E.; Andrews, L.; et al. Informed consent for genetic research on stored tissue samples. JAMA 1995, 274, 1786-1792.
12. Bosman, F.T.; deGoeij, A.F.; Rousch,M.Quality control in immunocytochemistry: experiences with the oestrogen receptor assay. J Clin Pathol 1992, 45, 120-124.
13. Rau, B.; Sturm, I.; Lage, H.; Berger, S.; Schneider, U.; et al. Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy. J Clin Oncol 2003, 21, 3391-3401.
14. Zhu, X.; Raina, A.K.; Smith, M.A. Cell cycle events in neurons: Proliferation or death? Am J Pathol 1999, 155, 327-329.
15. Doherty, S.C.; McKeown, S.R.;McKelvey-Martin, V.; Downes, C.S.; Atala, A.; et al. Cell cycle checkpoint function in bladder cancer. J Natl Cancer Inst 2003, 95, 1859-1868.
16. Stewart, Z.A.; Mays, D.; Pietenpol, J.A. Defective G1-S cell cycle checkpoint function sensitizes cells to microtubule inhibitor-induced apoptosis. Cancer Res 1999, 59, 3831-3837.
17. Zheng, Y.L.; Loffredo, C.A.; Alberg, A.J.; Yu, Z.; Jones, R.T.; et al. Less efficient g2-m checkpoint is associated with an increased risk of lung cancer in African Americans. Cancer Res 2005, 65, 9566-9573.
18. Fernando, R.; Foster, J.S.; Bible, A.; Strom, A.; Pestell, R.G.; et al. Breast cancer cell proliferation is inhibited by BAD: regulation of cyclin D1. J Biol Chem 2007, 282, 28864-28873.
19. Dosaka-Akita, H.; Katabami, M.; Hommura, H.; Fujioka, Y.; Katoh, H.; Kawakami, Y. Bcl-2 expression in non-small cell lung cancers: Higher frequency of expression in squamous cell carcinomas with earlier pT status. Oncology 1999, 56, 259-264.
20. Bowden, G.T.; Schneider, B.; Domann, R.; Kulesz-Martin, M. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis. Cancer Res 1994, 54, 1882s-1885s.
21. Jemal, A.; Siegel, R.; Ward, E.; Murray, T.; Xu, J.; et al. Cancer statistics, 2006. CA Cancer J Clin 2006, 56, 106-130.
22. Parkin, D.M.; Bray, F.; Ferlay, J.; Pisani, P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55, 74-108.
23. Simchoni, S.; Friedman, E.; Kaufman, B.; Gershoni-Baruch, R.; Orr-Urtreger, A.; et al. Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population. Proc Natl Acad Sci USA 2006, 103, 3770-3774.
24. Hughes-Davies, L.; Huntsman, D.; Ruas, M.; Fuks, F.; Bye, J.; et al. EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell 2003, 115, 523-535.